Home › Neuroendocrine Tumors
Pag-aaral pangklinika para sa Neuroendocrine Tumors na nagre-recruit sa U.S.
39 pag-aaral para sa Neuroendocrine Tumors ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Washington, DC11 pag-aaral
- St. Louis, MO9 pag-aaral
- Philadelphia, PA8 pag-aaral
- Houston, TX7 pag-aaral
- Columbus, OH7 pag-aaral
- Rochester, MN7 pag-aaral
- Portland, OR6 pag-aaral
- Cleveland, OH6 pag-aaral
- Mountain View, CA6 pag-aaral
- Boston, MA6 pag-aaral
- Dallas, TX6 pag-aaral
- Los Angeles, CA6 pag-aaral
- Chicago, IL6 pag-aaral
- San Francisco, CA5 pag-aaral
- Salt Lake City, UT5 pag-aaral
- Nashville, TN5 pag-aaral
- Seattle, WA5 pag-aaral
- Omaha, NE5 pag-aaral
- Jacksonville, FL5 pag-aaral
- Cedar Rapids, IA5 pag-aaral
- Ann Arbor, MI4 pag-aaral
- Detroit, MI4 pag-aaral
- Lexington, KY4 pag-aaral
- Durham, NC4 pag-aaral
- Grand Rapids, MI4 pag-aaral
- Milwaukee, WI4 pag-aaral
- Charlottesville, VA4 pag-aaral
- Fargo, ND4 pag-aaral
- New York City, NY4 pag-aaral
- Miami, FL4 pag-aaral
- Cincinnati, OH3 pag-aaral
- Arlington, VA3 pag-aaral
- Phoenix, AZ3 pag-aaral
- Birmingham, AL3 pag-aaral
- Orlando, FL3 pag-aaral
- Albuquerque, NM3 pag-aaral
- Tampa, FL3 pag-aaral
- Buffalo, NY3 pag-aaral
- New Orleans, LA3 pag-aaral
- Baldwin Park, CA3 pag-aaral
Ayos sa estado
- Alabama3 pag-aaral
- Arizona5 pag-aaral
- California13 pag-aaral
- Colorado3 pag-aaral
- Connecticut3 pag-aaral
- Florida9 pag-aaral
- Georgia3 pag-aaral
- Illinois7 pag-aaral
- Iowa6 pag-aaral
- Kentucky4 pag-aaral
- Louisiana4 pag-aaral
- Maryland13 pag-aaral
- Massachusetts8 pag-aaral
- Michigan8 pag-aaral
- Minnesota9 pag-aaral
- Missouri10 pag-aaral
- Nebraska5 pag-aaral
- New Mexico3 pag-aaral
- New York5 pag-aaral
- North Carolina5 pag-aaral
- North Dakota4 pag-aaral
- Ohio12 pag-aaral
- Oregon6 pag-aaral
- Pennsylvania8 pag-aaral
- Tennessee6 pag-aaral
- Texas10 pag-aaral
- Utah5 pag-aaral
- Virginia5 pag-aaral
- Washington5 pag-aaral
- Wisconsin6 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06805825A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
Nagre-recruitPhase 2
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06406465Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05237934Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Nagre-recruit
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04907643Multicenter Study for External Validation of the TB-NET Score
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07903532Study of CTX-471 in Patients With Neural Cell Adhesion Molecule (NCAM) Positive Neuroendocrine Neoplasms
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07684170A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06041516Somatostatin Analogues vs. Observation After Peptide Receptor Radionuclide Therapy (PRRT) in Nonfunctional Neuroendocrine Neoplasms
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07842172Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07165132Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06943755Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Nagre-recruitPhase 2
Edad 18 hanggang 72 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT03412877Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Nagre-recruitPhase 1
24 Months – 18 Years · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT06441331A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT05160480Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
Nagre-recruitPhase 2
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT03206060Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT04074135Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)
Nagre-recruitPhase 1/2
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT04086485Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT06926634Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
Nagre-recruitPhase 1/2
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT05636618CapTemY90 for Grade 2/3 NET Liver Metastases
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT04339036A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06881992EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06263088Project: Every Child for Younger Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 25 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT02402244The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT07151391An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT07132645Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT05263050Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.